RAFAEL HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
RAFAEL HOLDINGS, INC. (RFL) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of -$255.00 thousand for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was -$255.00K.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2021 was -$18.00K, a 162.07% decline from fiscal 2020.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2020 was $29.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month as first filed |
|---|---|---|
| 2023-07-31 | -$255.00K 10-K · filed 2023-10-30 | |
| 2021-07-31 | -$18.00K 10-K · filed 2022-10-31 | $18.00K 10-K · filed 2021-10-18 |
| 2020-07-31 | $29.00K 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |